Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTE

PolarityTE (PTE) Stock Price, News & Analysis

PolarityTE logo

About PolarityTE Stock (NASDAQ:PTE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$0.57
52-Week Range
N/A
Volume
8.50 million shs
Average Volume
249,591 shs
Market Capitalization
$1.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter.

PTE Stock News Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Regenetp Inc RGTPQ
RegenETP, Inc. (NJT.SG)
PolarityTE Stock (NASDAQ:PTE), Dividends
See More Headlines

PTE Stock Analysis - Frequently Asked Questions

PolarityTE, Inc. (NASDAQ:PTE) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($2.25) EPS for the quarter, topping the consensus estimate of ($3.00) by $0.75. The business had revenue of $1.12 million for the quarter, compared to the consensus estimate of $0.97 million.

Shares of PolarityTE reverse split before market open on Tuesday, May 17th 2022.The 1-25 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that PolarityTE investors own include Bionano Genomics (BNGO), Acasti Pharma (ACST), T2 Biosystems (TTOO), SNDL (SNDL), Zomedica (ZOM), Tonix Pharmaceuticals (TNXP) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/10/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PTE
CIK
1076682
Employees
42
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
($3.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.83 million
Net Margins
N/A
Pretax Margin
-11,376.71%
Return on Equity
-106.08%
Return on Assets
-76.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.11
Quick Ratio
4.11

Sales & Book Value

Annual Sales
$810 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.30 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,380,000
Free Float
6,978,000
Market Cap
$1.78 million
Optionable
Optionable
Beta
1.15

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PTE) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners